Corrigendum to "D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats" [Eur. J. Pharmacol. 862 (2019) 172632].

Autor: Dutta AK; Wayne State University, Department of Pharmaceutical Sciences, Detroit, MI, 48202, USA. Electronic address: adutta@wayne.edu., Santra S; Wayne State University, Department of Pharmaceutical Sciences, Detroit, MI, 48202, USA., Harutyunyan A; Department of Psychiatry and Behavioral Neurosciences, School of Medicine, Wayne State University, USA., Das B; Wayne State University, Department of Pharmaceutical Sciences, Detroit, MI, 48202, USA., Lisieski MJ; Department of Psychiatry and Behavioral Neurosciences, School of Medicine, Wayne State University, USA., Xu L; Wayne State University, Department of Pharmaceutical Sciences, Detroit, MI, 48202, USA., Antonio T; New York University, Department of Psychiatry, New York, NY, 10016, USA., Reith MEA; New York University, Department of Psychiatry, New York, NY, 10016, USA., Perrine SA; Department of Psychiatry and Behavioral Neurosciences, School of Medicine, Wayne State University, USA.
Jazyk: angličtina
Zdroj: European journal of pharmacology [Eur J Pharmacol] 2022 Oct 15; Vol. 933, pp. 175286. Date of Electronic Publication: 2022 Sep 24.
DOI: 10.1016/j.ejphar.2022.175286
Databáze: MEDLINE
Externí odkaz: